Rockwell Medical Stock Analysis

RMTI Stock  USD 2.31  0.06  2.67%   
Rockwell Medical is undervalued with Real Value of 3.68 and Target Price of 8.0. The main objective of Rockwell Medical stock analysis is to determine its intrinsic value, which is an estimate of what Rockwell Medical is worth, separate from its market price. There are two main types of Rockwell Medical's stock analysis: fundamental analysis and technical analysis.
The Rockwell Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Rockwell Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Rockwell Stock Analysis Notes

About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Rockwell Medical was at this time reported as 0.73. The company recorded a loss per share of 0.04. Rockwell Medical had not issued any dividends in recent years. The entity had 1:11 split on the 13th of May 2022. Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people. To find out more about Rockwell Medical contact Mark Strobeck at 248 960 9009 or learn more at https://www.rockwellmed.com.

Rockwell Medical Quarterly Total Revenue

28.32 Million

Rockwell Medical Investment Alerts

Rockwell Medical generated a negative expected return over the last 90 days
Rockwell Medical has high historical volatility and very poor performance
Rockwell Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 83.61 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 4.08 M.
Rockwell Medical currently holds about 27.56 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Rockwell Medical has a frail financial position based on the latest SEC disclosures
Roughly 12.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: Microsoft Corporation and Rockwell Team Up to Revolutionize Manufacturing with AI and Cloud Solutions

Rockwell Medical Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Rockwell Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Rockwell Largest EPS Surprises

Earnings surprises can significantly impact Rockwell Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-14
2024-03-31-0.04-0.06-0.0250 
2024-03-21
2023-12-31-0.07-0.050.0228 
2023-11-14
2023-09-30-0.1-0.070.0330 
View All Earnings Estimates

Rockwell Medical Environmental, Social, and Governance (ESG) Scores

Rockwell Medical's ESG score is a quantitative measure that evaluates Rockwell Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Rockwell Medical's operations that may have significant financial implications and affect Rockwell Medical's stock price as well as guide investors towards more socially responsible investments.

Rockwell Stock Institutional Investors

Shares
Bailard Inc2024-09-30
72.8 K
Northern Trust Corp2024-09-30
63.4 K
Hillsdale Investment Management Inc.2024-09-30
60.8 K
Cubist Systematic Strategies, Llc2024-09-30
57.2 K
Algert Global Llc2024-09-30
50.9 K
Millennium Management Llc2024-06-30
47.8 K
Wealthtrust Axiom Llc2024-09-30
38 K
Baader Bank Inc2024-09-30
35.8 K
Hightower Advisors, Llc2024-06-30
32.7 K
Armistice Capital, Llc2024-09-30
3.6 M
Vanguard Group Inc2024-09-30
1.2 M
Note, although Rockwell Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Rockwell Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.72 M.

Rockwell Profitablity

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.19)(0.20)
Return On Assets(0.16)(0.17)
Return On Equity(0.40)(0.42)

Management Efficiency

Rockwell Medical has return on total asset (ROA) of (0.0425) % which means that it has lost $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.289) %, meaning that it created substantial loss on money invested by shareholders. Rockwell Medical's management efficiency ratios could be used to measure how well Rockwell Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.22. The current Return On Capital Employed is estimated to decrease to -0.2. As of now, Rockwell Medical's Total Current Assets are increasing as compared to previous years. The Rockwell Medical's current Intangible Assets is estimated to increase to about 13 M, while Total Assets are projected to decrease to under 37.3 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.91  0.87 
Tangible Book Value Per Share 0.41  0.39 
Enterprise Value Over EBITDA(10.34)(10.86)
Price Book Value Ratio 2.07  1.97 
Enterprise Value Multiple(10.34)(10.86)
Price Fair Value 2.07  1.97 
Enterprise Value48.5 M88.2 M
Understanding the operational decisions made by Rockwell Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
0.0199
Profit Margin
(0.05)
Beta
1.503
Return On Assets
(0.04)
Return On Equity
(0.29)

Technical Drivers

As of the 25th of November, Rockwell Medical holds the Coefficient Of Variation of (4,997), risk adjusted performance of (0.01), and Variance of 48.05. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rockwell Medical, as well as the relationship between them.

Rockwell Medical Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Rockwell Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Rockwell Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Rockwell Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rockwell Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rockwell Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rockwell Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Rockwell Medical Outstanding Bonds

Rockwell Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rockwell Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rockwell bonds can be classified according to their maturity, which is the date when Rockwell Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Rockwell Medical Predictive Daily Indicators

Rockwell Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rockwell Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Rockwell Medical Corporate Filings

F4
19th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13th of November 2024
Other Reports
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8th of October 2024
Other Reports
ViewVerify
3rd of October 2024
Other Reports
ViewVerify
F4
2nd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
20th of August 2024
Other Reports
ViewVerify

Rockwell Medical Forecast Models

Rockwell Medical's time-series forecasting models are one of many Rockwell Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rockwell Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Rockwell Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rockwell Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rockwell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rockwell Medical. By using and applying Rockwell Stock analysis, traders can create a robust methodology for identifying Rockwell entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.10)(0.11)
Operating Profit Margin(0.08)(0.08)
Net Loss(0.10)(0.11)
Gross Profit Margin 0.10  0.11 

Current Rockwell Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rockwell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rockwell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
8.0Buy2Odds
Rockwell Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Rockwell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Rockwell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Rockwell Medical, talking to its executives and customers, or listening to Rockwell conference calls.
Rockwell Analyst Advice Details

Rockwell Stock Analysis Indicators

Rockwell Medical stock analysis indicators help investors evaluate how Rockwell Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rockwell Medical shares will generate the highest return on investment. By understating and applying Rockwell Medical stock analysis, traders can identify Rockwell Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow10.1 M
Long Term Debt8.3 M
Common Stock Shares Outstanding23.3 M
Total Stockholder Equity21.3 M
Property Plant And Equipment Net11 M
Cash And Short Term Investments10.9 M
CashM
Accounts Payable4.5 M
Net Debt4.5 M
50 Day M A3.5278
Total Current Liabilities16.6 M
Other Operating Expenses90.3 M
Non Current Assets Total23.4 M
Forward Price Earnings32.1543
Non Currrent Assets Other705 K
Stock Based Compensation932 K

Complementary Tools for Rockwell Stock analysis

When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio